These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
225 related articles for article (PubMed ID: 20415805)
21. Teriparatide therapy for bisphosphonate-associated osteonecrosis of the jaw in an elderly Japanese woman with severe osteoporosis. Iwamoto J; Yago K; Sato Y; Matsumoto H Clin Drug Investig; 2012 Aug; 32(8):547-53. PubMed ID: 22734599 [TBL] [Abstract][Full Text] [Related]
23. Bisphosphonate-induced osteonecrosis of the jaws, bone markers, and a hypothesized candidate gene. Lehrer S; Montazem A; Ramanathan L; Pessin-Minsley M; Pfail J; Stock RG; Kogan R J Oral Maxillofac Surg; 2009 Jan; 67(1):159-61. PubMed ID: 19070762 [TBL] [Abstract][Full Text] [Related]
24. Oral bisphosphonate use and the prevalence of osteonecrosis of the jaw: an institutional inquiry. Sedghizadeh PP; Stanley K; Caligiuri M; Hofkes S; Lowry B; Shuler CF J Am Dent Assoc; 2009 Jan; 140(1):61-6. PubMed ID: 19119168 [TBL] [Abstract][Full Text] [Related]
25. Bisphosphonate-associated osteonecrosis of the jaw: the rheumatologist's role. Capsoni F; Longhi M; Weinstein R Arthritis Res Ther; 2006; 8(5):219. PubMed ID: 17049069 [TBL] [Abstract][Full Text] [Related]
26. Dental sinus tracts mimicking scrofuloderma: cutaneous presentation of underlying bisphosphonate-related osteonecrosis of the jaw. Kang HS; Lee JW; Kim JS Clin Exp Dermatol; 2011 Aug; 36(6):624-7. PubMed ID: 21771007 [TBL] [Abstract][Full Text] [Related]
27. Treatment of Osteonecrosis of the Jaw. Yamachika E; Matsubara M; Ikeda A; Matsumura T; Moritani N; Iida S J Craniofac Surg; 2015 Oct; 26(7):e575-7. PubMed ID: 26468825 [TBL] [Abstract][Full Text] [Related]
28. Intravenous bisphosphonate-related osteonecrosis of the jaw: bone scintigraphy as an early indicator. O'Ryan FS; Khoury S; Liao W; Han MM; Hui RL; Baer D; Martin D; Liberty D; Lo JC J Oral Maxillofac Surg; 2009 Jul; 67(7):1363-72. PubMed ID: 19531404 [TBL] [Abstract][Full Text] [Related]
29. Osteonecrosis of the jaw induced by orally administered bisphosphonates: incidence, clinical features, predisposing factors and treatment outcome. Yarom N; Yahalom R; Shoshani Y; Hamed W; Regev E; Elad S Osteoporos Int; 2007 Oct; 18(10):1363-70. PubMed ID: 17598065 [TBL] [Abstract][Full Text] [Related]
30. Bone necrosis of the jaws associated with bisphosphonate treatment: a report of twenty-nine cases. Merigo E; Manfredi M; Meleti M; Guidotti R; Ripasarti A; Zanzucchi E; D'Aleo P; Corradi D; Corcione L; Sesenna E; Ferrari S; Poli T; Bonaninil M; Vescovi P Acta Biomed; 2006 Aug; 77(2):109-17. PubMed ID: 17172192 [TBL] [Abstract][Full Text] [Related]
31. The influence of alendronate and tooth extraction on the incidence of osteonecrosis of the jaw among osteoporotic subjects. Chiu WY; Yang WS; Chien JY; Lee JJ; Tsai KS PLoS One; 2018; 13(4):e0196419. PubMed ID: 29694412 [TBL] [Abstract][Full Text] [Related]
32. Antiresorptives and osteonecrosis of the jaw. Yamashita J; McCauley LK J Evid Based Dent Pract; 2012 Sep; 12(3 Suppl):233-47. PubMed ID: 23040351 [TBL] [Abstract][Full Text] [Related]
33. Bisphosphonate-related osteonecrosis of jaws in 3 osteoporotic patients with history of oral bisphosphonate use treated with single yearly zoledronic acid infusion. Fitzpatrick SG; Stavropoulos MF; Bowers LM; Neuman AN; Hinkson DW; Green JG; Bhattacharyya I; Cohen DM J Oral Maxillofac Surg; 2012 Feb; 70(2):325-30. PubMed ID: 21723015 [No Abstract] [Full Text] [Related]
34. Surgically treated osteonecrosis and osteomyelitis of the jaw and oral cavity in patients highly adherent to alendronate treatment: a nationwide user-only cohort study including over 60,000 alendronate users. Eiken PA; Prieto-Alhambra D; Eastell R; Abrahamsen B Osteoporos Int; 2017 Oct; 28(10):2921-2928. PubMed ID: 28664276 [TBL] [Abstract][Full Text] [Related]
35. Consequence of therapy discontinuation in bisphosphonate-associated osteonecrosis of the jaws. Gallego L; Junquera L Br J Oral Maxillofac Surg; 2009 Jan; 47(1):67-8. PubMed ID: 18639371 [TBL] [Abstract][Full Text] [Related]
36. Pentoxifylline and tocopherol in the treatment of yearly zoledronic acid-related osteonecrosis of the jaw in a corticosteroid-induced osteoporosis. Magremanne M; Reychler H J Oral Maxillofac Surg; 2014 Feb; 72(2):334-7. PubMed ID: 23891014 [TBL] [Abstract][Full Text] [Related]
37. Administration of teriparatide improves the symptoms of advanced bisphosphonate-related osteonecrosis of the jaw: preliminary findings. Kakehashi H; Ando T; Minamizato T; Nakatani Y; Kawasaki T; Ikeda H; Kuroshima S; Kawakami A; Asahina I Int J Oral Maxillofac Surg; 2015 Dec; 44(12):1558-64. PubMed ID: 26304604 [TBL] [Abstract][Full Text] [Related]
38. Bisphosphonate-associated osteonecrosis: a clinician's reference to patient management. Grewal VS; Fayans EP Todays FDA; 2008 Aug; 20(8):38-41, 43-6. PubMed ID: 18767452 [TBL] [Abstract][Full Text] [Related]
39. [Osteonecrosis of the jaw]. Drozdzowska B Endokrynol Pol; 2011; 62 Suppl 3():4-9. PubMed ID: 22161980 [TBL] [Abstract][Full Text] [Related]
40. Bisphosphonate-related osteonecrosis of the jaws: a single-center study of 101 patients. Lazarovici TS; Yahalom R; Taicher S; Elad S; Hardan I; Yarom N J Oral Maxillofac Surg; 2009 Apr; 67(4):850-5. PubMed ID: 19304045 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]